Invasive pneumococcal disease in HIV-infected adults: clinical changes after the introduction of the pneumococcal conjugate vaccine in children
J Burgos, M Peñaranda, A Payeras… - JAIDS Journal of …, 2012 - journals.lww.com
Background Few data exist on the implications of widespread use of 7-valent pneumococcal
conjugate vaccine in children in the invasive pneumococcal disease (IPD) in HIV-infected …
conjugate vaccine in children in the invasive pneumococcal disease (IPD) in HIV-infected …
Risk factors for invasive pneumococcal disease in HIV-infected adults in France in the highly active antiretroviral therapy era
AL Munier, V de Lastours, R Porcher… - … journal of STD & …, 2014 - journals.sagepub.com
Invasive pneumococcal diseases remain frequent and severe in HIV-infected subjects. To
identify opportunities for prevention, we assessed risk factors of invasive pneumococcal …
identify opportunities for prevention, we assessed risk factors of invasive pneumococcal …
Estimated severe pneumococcal disease cases and deaths before and after pneumococcal conjugate vaccine introduction in children younger than 5 years of age in …
C Von Mollendorf, S Tempia, A Von Gottberg… - PloS one, 2017 - journals.plos.org
Introduction Streptococcus pneumoniae is a leading cause of severe bacterial infections
globally. A full understanding of the impact of pneumococcal conjugate vaccine (PCV) on …
globally. A full understanding of the impact of pneumococcal conjugate vaccine (PCV) on …
Dynamics of invasive pneumococcal disease in Israel in children and adults in the 13-valent pneumococcal conjugate vaccine (PCV13) era: a nationwide prospective …
S Ben-Shimol, G Regev-Yochay… - Clinical Infectious …, 2022 - academic.oup.com
Background Following 13-valent pneumococcal conjugate vaccine (PCV13) implementation
in infants worldwide, overall and vaccine-type invasive pneumococcal disease (IPD) rates …
in infants worldwide, overall and vaccine-type invasive pneumococcal disease (IPD) rates …
Incidence and risk factors for invasive pneumococcal disease and community-acquired pneumonia in human immunodeficiency virus–infected individuals in a high …
HM Garcia Garrido, AMR Mak, FWNM Wit… - Clinical Infectious …, 2020 - academic.oup.com
Background Although people living with human immunodeficiency virus (PLWH) are at
increased risk of invasive pneumococcal disease (IPD) and community-acquired pneumonia …
increased risk of invasive pneumococcal disease (IPD) and community-acquired pneumonia …
Invasive pneumococcal disease in a cohort of HIV-infected adults: incidence and risk factors, 1990–2003
PM Barry, N Zetola, JC Keruly, RD Moore, KA Gebo… - Aids, 2006 - journals.lww.com
Objective: To investigate the association between the introduction of HAART and invasive
pneumococcal disease (IPD) in HIV-infected patients. Methods: Incidence of IPD was …
pneumococcal disease (IPD) in HIV-infected patients. Methods: Incidence of IPD was …
Reduction of invasive pneumococcal disease 3 years after the introduction of the 13-valent conjugate vaccine in the Oxfordshire region of England
CE Moore, J Paul, D Foster, SA Mahar… - The Journal of …, 2014 - academic.oup.com
Background. The 7-valent pneumococcal conjugate (PCV7) vaccine's impact on invasive
pneumococcal disease (IPD) is well described, but few reports exist on the additional impact …
pneumococcal disease (IPD) is well described, but few reports exist on the additional impact …
Invasive pneumococcal disease (IPD) in HIV infected patients in Israel since the introduction of pneumococcal conjugated vaccines (PCV): Analysis of a nationwide …
M Chowers, G Regev-Yochay, O Mor… - Human Vaccines & …, 2017 - Taylor & Francis
Study aim: to assess the incidence, risk factors and outcome of invasive pneumococcal
disease (IPD) among the Israeli HIV population. A matched case-control study nested in a …
disease (IPD) among the Israeli HIV population. A matched case-control study nested in a …
Pneumococcal conjugate vaccine in HIV-infected and HIV-exposed, uninfected children
Introduction: Incidence of invasive pneumococcal disease (IPD) among HIV-infected
children is 20–40 fold greater compared to HIV-uninfected children, including among HIV …
children is 20–40 fold greater compared to HIV-uninfected children, including among HIV …
Disappearance of vaccine-type invasive pneumococcal disease and emergence of serotype 19A in a minority population with a high prevalence of human …
A Tasslimi, EJ Sison, E Story, D Alland… - Clinical and Vaccine …, 2009 - Am Soc Microbiol
We analyzed the epidemiology of invasive pneumococcal disease (IPD) following
introduction of pneumococcal conjugated vaccine in an urban population with a 2% human …
introduction of pneumococcal conjugated vaccine in an urban population with a 2% human …